Medical Devices Series A Investors & VC Firms
1145 firms in this list, with a median first check of $500K. 237 of them lead rounds. Generated from verified public data and updated continuously.
Clarevia Ventures
MadisonSeed–Series A$250K – $2.5M
11 people
InHealth Ventures
LondonPre-Seed–Series A$500K – $3M
5 people
Korea Investment Partners
SeoulSeed–Late Stage$973K – $50M
17 people
MedStartr Ventures
New YorkSeed–Series A
11 people
TiVenture SA
LuganoPre-Seed–Series B
5 people
1955 Capital
San FranciscoPre-Seed–Series A$5M – $10M
7 people
GENIUS Venture Capital
SchwerinPre-Seed–Series A$540K – $1.6M
4 people
Taiho Ventures, LLC
Menlo ParkSeed–Series B
7 people
Bonaventure Equity, LLC
RaleighPre-Seed–Series A
12 people
Lang Sheng Investment Group Co. Ltd.
ShanghaiPre-Seed–Series B
9 people
Prospect Venture Partners
Menlo ParkSeed–Late Stage$3M – $5M
3 people
Aescap Life Sciences
AmsterdamSeed–Growth
14 people
DIA
CaryPre-Seed–Series A
8 people
Lemhi Ventures
JordanSeed–Late Stage$500K – $5M
5 people
Sodero
NantesSeed–Late Stage$162K – $5.4M
11 people
Sugati Ventures
San RamonSeed–Series A
11 people
Netrix Ventures
Pre-Seed–Series A
2 people
SATUS Venture Sp. z o.o.
KrakówPre-Seed–Series A$108K – $6.5M
2 people
BlueTree Venture Capital
WexfordSeed–Series A
7 people
Welltech Ventures
Tel AvivSeed–Series A
10 people
Critical Ventures
CoimbraSeed–Series B$550K – $3.3M
9 people
Pave Health Ventures
SeattlePre-Seed–Series A
12 people
Rex Health Ventures
RaleighSeed–Series B$250K – $500K
9 people
TSP Ventures
LondonPre-Seed–Series A
12 people
Related lists
Series A Investors & VC Firms (7875)Series A Investors & VC Firms in United States (3337)SaaS Series A Investors & VC Firms (2667)AI & Machine Learning Series A Investors & VC Firms (2343)Enterprise Software Series A Investors & VC Firms (2324)Fintech Series A Investors & VC Firms (2239)Healthtech Series A Investors & VC Firms (2210)Series A Investors & VC Firms in Global (2163)Consumer Series A Investors & VC Firms (1652)Series A Investors & VC Firms in Europe (1634)
Data sourced from public filings and firms' own websites — see our methodology.























































